v3.25.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Cash flows from operating activities:    
Net loss $ (7,701) $ (12,697)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of convertible debentures 1,095
Depreciation and amortization of property, plant and equipment 955 874
Share-based compensation charges 523 1,543
Share-based 401(k) employer match expense 494
Unrealized foreign exchange (gain) loss (127) 764
Gain on operating lease termination (554)
Changes in operating assets and liabilities:    
Accounts receivable (377) 2,475
Inventories 1,064 636
Prepaid expenses and other assets 729 (88)
Accounts payable – trade (61) (7,654)
Accrued liabilities, other current liabilities and other liabilities (9,241) (12,062)
Total adjustments (6,535) (12,477)
Net cash used in operating activities (14,236) (25,174)
Cash flows from investing activities:    
Release of escrowed cash from Asset Purchase Agreement 5,000
Capital expenditures (904) (422)
Net cash provided by (used in) investing activities 4,096 (422)
Cash flows from financing activities:    
Payment of cash dividend (5,324)
Repayments under loan agreement (79) (110)
Cash payments for taxes related to net share settlements of equity awards (163) (474)
Net cash used in financing activities (5,566) (584)
Effect of exchange rate changes on cash and cash equivalents 28 (37)
Decrease in cash and cash equivalents (15,678) (26,217)
Cash and cash equivalents - beginning of period 52,371 83,373
Cash and cash equivalents - end of period $ 36,693 $ 57,156

Source